Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| University of Leicester | OTHER |
| Associacao Protectora dos Diabeticos de Portugal | OTHER |
| The Algarve Regional Health Administration | OTHER |
| University of Leipzig |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
To investigate whether the interactive family based lifestyle programme leads to behaviour change at 6 months with the primary outcome being increased levels of moderate to vigorous physical activity (MVPA).
To investigate whether the lifestyle programme results in changes to the following outcomes 3 and 6 months after baseline assessment (Child)
The Investigators will also include qualitative data collected from:
To investigate whether the lifestyle programme results in changes to the following outcomes 3 and 6 months after baseline assessment (Parent(s)/guardian(s))
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Control | No Intervention | The control participants will not receive the educational intervention but will be provided with a detailed advice leaflet for themselves and their parents/guardians. | |
| Intervention | Other | The educational intervention participants will receive the eight 90 minute sessions of an interactive family based lifestyle programme. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Interactive Lifestyle programme workshop | Behavioral | Participants will attend eight 90 minute sessions of an interactive lifestyle programme along with their parent(s)/guardian(s). |
| Measure | Description | Time Frame |
|---|---|---|
| The primary endpoint is to detect a change in objectively measured MVPA of 10 minutes per day within the intervention group at 6 months. | Participating children and adults will be asked to wear the wrist worn GENEActiv accelerometer (ActivInsights, Kimbolton, Cambridgeshire, UK) continuously for up to 8 days. | 6 months post baseline |
| Measure | Description | Time Frame |
|---|---|---|
| An increase in total volume of physical activity | Participating children and adults will be asked to wear the wrist worn GENEActiv accelerometer (ActivInsights, Kimbolton, Cambridgeshire, UK) continuously for up to 8 days. | 3 and 6 months |
| An increase in the proportion meeting MVPA guidelines |
Not provided
Inclusion Criteria:
Parents/guardians will answer questions in the eligibility questionnaire about their child and family health history. Participants will be invited to participate if they are 12-14 years old inclusive (12 years 0 days to 14 years 354 days old) and are identified as having the following risk factors for development of Type 2 Diabetes (which will be identified from the eligibility questionnaire):
BMI > 95th percentile for age and gender OR
BMI > 85th percentile PLUS one other from the following list:
Exclusion Criteria:
Young people will not be eligible for participation in the study if they are outside the age range of interest (<11 years and 364 days or >14 years and 1 day), have an existing diagnosis of Type 1 or Type 2 Diabetes, < 85th percentile. Young people will also be excluded if they themselves do not provide written assent or their parent/guardian does not provide written consent.
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Melanie J Davies, MD | University Hospitals, Leicester | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| University Hospitals of Leicester | Leicester | LE4 5PW | United Kingdom |
Non identifiable participant data will be only be shared with the study collaborators.
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D003924 | Diabetes Mellitus, Type 2 |
| D002908 | Chronic Disease |
| D009765 | Obesity |
| ID | Term |
|---|---|
| D003920 | Diabetes Mellitus |
| D044882 | Glucose Metabolism Disorders |
| D008659 | Metabolic Diseases |
| D009750 | Nutritional and Metabolic Diseases |
Not provided
Not provided
| OTHER |
| Technische Universität Dresden | OTHER |
| Alexander Technological Educational Institute, Thessaloniki, Greece | OTHER |
| Diabetes Centre of Paediatrics P&A | UNKNOWN |
| Primary Care Centre Egia, San Sebastian, Spain | UNKNOWN |
| Basque Government Department of Public Health | OTHER |
| Health Department of the Alto/Bajo Deba | OTHER |
Not provided
Not provided
Not provided
Not provided
Not provided
Participating children and adults will be asked to wear the wrist worn GENEActiv accelerometer (ActivInsights, Kimbolton, Cambridgeshire, UK) continuously for up to 8 days. |
| 3 and 6 months |
| Reduction in time spent sedentary | Participating children and adults will be asked to wear the wrist worn GENEActiv accelerometer (ActivInsights, Kimbolton, Cambridgeshire, UK) continuously for up to 8 days. | 3 and 6 months |
| Change in physical activity levels | Self reported - questionnaire | 3 and 6 months |
| Reduction in Body mass index percentile (BMI) | Body mass will be measured to the nearest 0.1kg and height will be measured to the nearest 0.1 cm using a clinically approved bioelectrical impedance scale and a portable stadiometer, respectively. BMI will be calculated as weight/height2 and will be converted to a BMI percentile based on WHO growth charts | 3 and 6 months |
| Change in healthy food provision and parenting practices for healthy food | As parents are active participants in the intervention The Investigators will also query their knowledge and attitudes towards healthy eating and physical activity. | 3 and 6 months |
| Improvement in diet composition | The Investigators will query the nutrition habits of participants to investigate any changes in the behaviours targeted in the workshops. A food frequency questionnaire (FFQ) taken from the ISCOLE study that was adapted from the HBSC Study will be used to query the consumption of 23 food categories in a "usual" week. The Investigators will also query breakfast consumption for weekdays and weekends. The Investigators have also created ad hoc questions on other intervention targets of snacking behaviours, fruit and vegetable intake and fizzy drink consumption. This ad hoc method has been used in other international multi-site studies. | 3 and 6 months |
| Improvement in knowledge of physical activity and nutrition | The physical activity questionnaire for adolescents (PAQ-A) [62] will be used to assess the Types and context of physical activity in order to investigate changes in the Types of sports/exercise/activities the participating child may participate in (information which is not available from the accelerometer or the majority of other validated self-report questionnaires). This questionnaire requests responses for the last 7 days by asking participants to check a list of activities for frequency of participation. This questionnaire has received support from an expert panel and has also high validity against objective measures and moderate reliability. | 3 and 6 months |
| Improvement in HbA1c | Biochemical measures (Child only) - HbA1c | 3 and 6 months |
| Improvement in Triglycerides | Biochemical measures (Child only) - Triglycerides | 3 and 6 months |
| Improvement in Glucose | Biochemical measures (Child only) - Glucose | 3 and 6 months |
| Improvement in HDL-C | Biochemical measures (Child only) HDL-C | 3 and 6 months |
| Improvement in Total Cholesterol | Biochemical measures (Child only) -Total cholesterol will be measured using a point-of-care testing (POCT) and LDL-C will be calculated. | 3 and 6 months |
| Improvement in cardio-metabolic variables | Biochemical measures (Child only) - Capillary blood samples will be taken from each child using the finger prick method. The CardioChek® system will be used as the POCT method. The CardioChek® system is a portable hand held device that requires between 15 to 40 µL capillary sample from a finger-stick for each test. The CardioChek® system is certified by the Cholesterol Reference Method Laboratory Network (CRMLN) and National Cholesterol Education Program (NCEP), is FDA-cleared, CE-marked, internationally registered, and is CLIA-waived by the Centers for Medicare & Medicaid Services, USA. | 3 and 6 months |
| Blood Pressure (Child) | Arterial blood pressure will be measured using an automated sphygmomanometer with an appropriate sized cuff while the patient is seated, and having rested quietly for 5 minutes. Three measurements will be obtained for blood pressure and an average of the last two will be used in any analysis. | 3 and 6 months |
| Blood Pressure (Parent(s)/guardian(s)) | Arterial blood pressure will be measured using an automated sphygmomanometer with an appropriate sized cuff while the patient is seated, and having rested quietly for 5 minutes. Three measurements will be obtained for blood pressure and an average of the last two will be used in any analysis. | 3 and 6 months |
| D004700 | Endocrine System Diseases |
| D020969 | Disease Attributes |
| D010335 | Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |
| D050177 | Overweight |
| D044343 | Overnutrition |
| D009748 | Nutrition Disorders |
| D001835 | Body Weight |
| D012816 | Signs and Symptoms |